Secondary analysis of a crossover trial in 106 patients with HFpEF: vs dapagliflozin alone, spironolactone/dapagliflozin lowered systolic BP by 10.9 mm Hg in those with low renin (≤21 mU/L) but not significantly at higher renin. Aldosterone did not predict response.
Secondary analysisn = 106
Ferreira et al. Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEF